Abstract
The thermosensitive–mucoadhesive ondansetron liquid suppository (tmOLS) was developed to enhance patient compliance and bioavailability in high-risk patients receiving highly emetogenic therapy and having difficulty in swallowing, The thermosensitive–mucoadhesive liquid suppository bases were formulated using poloxamers (P407 and P188) and hydroxypropylmethyl cellulose (HPMC). The physicochemical properties of the liquid suppository bases were characterized by their gelation temperature, mucoadhesive force, rheological properties, and in vitro release. Rectal mucosal damage following rectal administration of tmOLS in rats was assessed using microscopy. Pharmacokinetic analyses were performed to compare tmOLS administered via the rectal route to ondansetron solution administered orally. The liquid suppository base of tmOLS contained P407, P188, and HPMC in the ratio 18:20:0.8, was in the liquid state at room temperature, underwent gelation at body temperature. Area under the curve and half-life (t1/2) of ondansetron were significantly higher in the tmOLS-treated group, indicating that the formulation bypassed the first-pass metabolism and that it was released slowly from the tmOLS because of the formation of mucoadhesive gel state. Furthermore, the t1/2 of tmOLS was two-fold that of the oral solution. Thus, tmOLS could be administered to patients who have difficulty in swallowing; however, adjustments in dosing interval may be needed.
Similar content being viewed by others
References
Altorjay, R., T. Melson, T. Chinachoit, A. Kett, K. Aqua, J. Levin, L.M. Blackburn, S. Lane, and J.V. Pergolizzi Jr. 2011. Casopitant and ondansetron for postoperative nausea and vomiting prevention in women at high risk for emesis. Archives of Surgery 146: 201–206.
Charrueau, C., C. Tuleu, V. Astre, J.L. Grossiord, and J.C. Grossiord. 2001. Poloxamer 407 as a thermogelling and adhesive polymer administration of short-chain fatty acids. Drug Development and Industrial Pharmacy 27: 351–357.
Choi, H.G., J.H. Hung, J.M. Ryu, S.J. Yoon, Y.K. Oh, and C.K. Kim. 1998a. Development of in situ gelling and mucoadhesive aceaminophen liquid suppository. International Journal of Pharmaceutics 165: 33–44.
Choi, H.G., Y.K. Oh, and C.K. Kim. 1998b. In-situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability. International Journal of Pharmaceutics 165: 23–32.
de Wit, R., J.H. Beijnen, O. van Tellingen, J.H. Schellens, M. de Boer-Dennert, and J. Verweij. 1996. Pharmacokinetic profile and clinical efficacy of a once-daily ondansetron suppository in cyclophosphamide-induced emesis: a double blind comparative study with ondansetron tablets. British Journal of Cancer 74: 323–326.
Edsman, K., J. Carlfors, and K. Harju. 1996. Rheological evaluation and ocular contact time of some carbomer gels for ophthalmic use. International Journal of Pharmaceutics 137: 233–241.
El Kamel, A.H. 2002. In vitro and in vivo evaluation of pluronic F 127-based ocular delivery system for timolol maleate. International Journal of Pharmaceutics 241: 47–55.
Jones, D.S., A.F. Brown, and A.D. Woolfsoon. 2001. Design, characterization and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. Journal of Controlled Release 67: 357–368.
Koffi, A.A., F. Agnely, M. Besnard, B.J. Kablan, J.L. Grossiord, and G. Ponchel. 2008. In vitro and in vivo characteristics of themogeling and bioadhesive delivery system intended for rectal administration of quinine in children. European Journal of Pharmaceutical Sciences 69: 167–175.
Lin, S.W., H.T. Hatoum, D. Buchner, D. Cox, and S. Balu. 2012. Impact of 5-HT3 receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study. BMC Health Service Research 12: 215.
Park, D.M., Y.K. Song, J.P. Jee, H.T. Kim, and C.K. Kim. 2012. Development of chitosan-based ondansetron buccal delivery system for the treatment of emesis. Drug Development and Industrial Pharmacy 38: 1077–1083.
Perioli, L., V. Ambrogi, D. Rubini, S. Giovagnoli, M. Ricci, P. Blasi, and C. Rossi. 2004. Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. Journal of Controlled Release 95: 521–533.
Salem, I.I., M.R. Lopez, and A.C. Galan. 2001. Ondansetron hydrochloride. In Analytical profiles of drug substances and excipients, ed. H.G. Brittan, 301–339. San Diego: Academic Press.
Sarkar, N. 1979. Thermal gelation properties of methyl and HPMC. Journal of Applied Polymer Science 24: 1073–1087.
Shaikh, R., T.R.R. Singh, M.J. Garland, A.D. Woolfson, and R.F. Donnelly. 2011. Mucoadhesive drug delivery systems. Journal of Pharmacy and Bioallied Sciences 3: 89–100.
Sweetman, S.C. 2011. Martindale: the complete drug reference, 37th ed. London: Pharmaceutical Press.
Ye, J.H., R. Ponnudurai, and R. Schaefer. 2001. Ondansetron: a selective 5-HT(3) receptor antagonist and its application in CNS-related disorders. CNS Drug Reviews 7: 199–213.
Yun, M., H.G. Choi, J. Jung, and C.K. Kim. 1999. Development of a thermoreversible insulin liquid suppository with bioavailability enhancement. International Journal of Pharmaceutics 189: 137–145.
Acknowledgments
This work was supported by the 2012 Inje University research Grant.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ban, E., Kim, CK. Design and evaluation of ondansetron liquid suppository for the treatment of emesis. Arch. Pharm. Res. 36, 586–592 (2013). https://doi.org/10.1007/s12272-013-0049-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-013-0049-y